Study ID: Novartis CFTY720D2405_TRANSITION
Description:

TRANSITION: A two-year observational study to evaluate the safety profile of fingolimod in patients with multiple sclerosis who switch from natalizumab to fingolimod

Location:
Fargo Region
Principal Investigator:
Susan Scarberry
Disease:
Stage:
N/A

Status:

Active - Open to Accrual

For more information, call or email Bismarck Clinical Research at (701) 323-5760, Fargo and Bemidji Clinical Research at (701) 234-5890, or Sioux Falls Clinical Research at (605) 328-1368.

Back to Clinical Trials list